NCT02636452View on ClinicalTrials.gov

Cardiopulmonary Exercise Testing in Interstitial Lung Disease

CompletedOBSERVATIONAL
Enrollment

58

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Interstitial Lung Disease
Interventions
OTHER

cardiopulmonary exercise test

Trial Locations (1)

42699

Bethanien Hospital, Clinic for Pneumology and Allergology, Center for Sleep and Respiratory Medicine, Solingen

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Wissenschaftliches Institut Bethanien e.V

OTHER

NCT02636452 - Cardiopulmonary Exercise Testing in Interstitial Lung Disease | Biotech Hunter | Biotech Hunter